Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonadrenergic imidazoline binding sites on human platelets

J E Piletz1, K Sletten

  • 1Department of Psychiatry, Case Western Reserve University, MetroHealth Medical Center, Cleveland, Ohio.

The Journal of Pharmacology and Experimental Therapeutics
|December 1, 1993
PubMed
Summary

Human platelets contain distinct imidazoline receptors, including I1 and I2 subtypes, and a novel guanabenz-sensitive site, separate from alpha-2 adrenoceptors. These findings offer insights into platelet function and imidazoline receptor research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative chemical study on population-specific odorants from atlantic salmon.

Journal of chemical ecology·2014
Same author

Properties of cod metallothionein, its presence in different tissues and effects of Cd and Zn treatment.

Fish physiology and biochemistry·2013
Same author

Alkali-degradation of amyloid: an ancient method useful for making monoclonal antibodies against amyloid fibril proteins.

Scandinavian journal of immunology·2009
Same author

Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.

Neuroscience·2005
Same author

Artefacts formed by addition of urea to N-linked glycans released with peptide-N-glycosidase F for analysis by mass spectrometry.

Rapid communications in mass spectrometry : RCM·2004
Same author

Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress.

Annals of the New York Academy of Sciences·2004

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Human platelets possess alpha-2 adrenoceptors.
  • Platelets exhibit unique aggregatory properties influenced by substances like clonidine.

Purpose of the Study:

  • To identify and characterize non-adrenergic, high-affinity binding sites in human platelets.
  • To investigate the heterogeneity and localization of these novel binding sites.

Main Methods:

  • Radioligand binding assays using [3H]idazoxan (IDX) and [125I]p-iodoclonidine (PIC) with norepinephrine masking.
  • Competition binding studies with various ligands to determine affinity constants.
  • Differential subcellular fractionation to localize binding sites.

Main Results:

Related Experiment Videos

  • Two distinct nonadrenergic, imidazoline-preferring binding sites were identified in human platelets.
  • Subtype-I1 imidazoline receptors were found in plasma membranes, while subtype-I2 receptors were located in both plasma and internal membranes.
  • A novel guanabenz-sensitive site was also detected, alongside alpha-2A adrenoceptors.

Conclusions:

  • Human platelets harbor multiple imidazoline receptor subtypes (I1 and I2) and a unique guanabenz-sensitive site.
  • These non-adrenoceptor sites may explain specific platelet aggregatory behaviors.
  • Platelet imidazoline receptors can serve as valuable markers for imidazoline receptor research in humans.